Innoviva (NASDAQ: INVA) reported Q1 EPS of ($0.74), $1.07 worse than the analyst estimate of $0.33. Revenue for the quarter came in at $88.63 million versus the consensus estimate of $81.63 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.